MARKET

INVA

INVA

Innoviva
NASDAQ
18.49
-0.54
-2.84%
Closed 19:30 11/16 EST
OPEN
19.08
PREV CLOSE
19.03
HIGH
19.24
LOW
18.41
VOLUME
814.14K
TURNOVER
0
52 WEEK HIGH
25.15
52 WEEK LOW
18.41
MARKET CAP
1.31B
P/E (TTM)
8.96
1D
5D
1M
3M
1Y
5Y
1D
Quarterly Loss Could Be A Game Changer For Innoviva (INVA)
Simply Wall St · 1d ago
Innoviva (INVA) And The Question Hanging Over Its Latest Update
Simply Wall St · 3d ago
H.C. Wainwright Keeps Their Buy Rating on Innoviva (INVA)
TipRanks · 3d ago
Impressive Earnings May Not Tell The Whole Story For Innoviva (NASDAQ:INVA)
Simply Wall St · 5d ago
INVA or MRK: Which Is the Better Value Stock Right Now?
NASDAQ · 11/09 15:40
Weekly Report: what happened at INVA last week (1102-1106)?
Weekly Report · 11/09 10:17
Innoviva (INVA) Stock Could Be Undervalued On Third Quarter Results
Simply Wall St · 11/06 04:56
Innoviva Price Target Cut to $34.00/Share From $35.00 by Oppenheimer
Dow Jones · 11/05 17:54
More
About INVA
Innoviva, Inc. is a diversified holding company with a portfolio of royalties and other healthcare assets. Its royalty portfolio includes respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI) and ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement, it is entitled to receive royalties from GSK on sales of RELVAR/BREO, ELLIPTA. Its products include GIAPREZA (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA (eravacycline) approved for the treatment of complicated intra-abdominal infections in adults. The third product, XACDURO, is for the treatment of hospital-acquired and ventilator-associated pneumonias caused by Acinetobacter in adults. The development pipeline includes zoliflodacin, an investigational treatment for uncomplicated gonorrhea is in a Phase III clinical trial.

Webull offers Innoviva Inc stock information, including NASDAQ: INVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INVA stock methods without spending real money on the virtual paper trading platform.